UniSuper Management Pty Ltd

Position in MRK — Merck & Co., Inc.

CIK 1989400 MELBOURNE, VICTORIA, C3

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$152,739,212

+$20,444,030 QoQ

Shares Held

1,188,632

+8.1% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.80%

of 13F equity value

Holder Rank

#165

of 3,769 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UniSuper Management Pty Ltd holds $763,193,679 across 9 Drug Manufacturers - General names. MRK ranks #3 (20.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	193,999	$232,688,239
2	JNJ	Johnson & Johnson	655,534	$166,485,969
3	MRK	Merck & Co., Inc. This page	1,188,632	$152,739,212
4	ABBV	AbbVie Inc.	369,817	$93,060,749
5	GILD	Gilead Sciences, Inc.	351,688	$44,432,261
6	AMGN	Amgen Inc	116,483	$42,180,823
7	PFE	Pfizer Inc	624,923	$15,048,145
8	BMY	Bristol Myers Squibb Co	224,641	$12,943,814

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$152,739,212	1,188,632	+8.1%	Shares	Sole	2026-08-14
2026-03-31	$132,295,182	1,099,802	+0.0%	Shares	Sole	2026-05-11
2025-12-31	$115,739,790	1,099,561	+1.1%	Shares	Sole	2026-02-12
2025-09-30	$91,242,233	1,087,123	+17.3%	Shares	Sole	2025-10-31
2025-06-30	$73,363,746	926,778	+3.6%	Shares	Sole	2025-07-22
2025-03-31	$80,291,127	894,509	+1.1%	Shares	Sole	2025-05-15
2024-12-31	$88,010,851	884,709	-2.2%	Shares	Sole	2025-02-12
2024-09-30	$102,739,548	904,716	-29.6%	Shares	Sole	2024-11-14
2024-06-30	$159,186,001	1,285,832	+53.4%	Shares	Sole	2024-08-05
2024-03-31	$110,582,412	838,063	+2.4%	Shares	Sole	2024-05-13
2023-12-31	$89,203,652	818,232	-2.3%	Shares	Sole	2024-02-13
2023-09-30	$86,191,901	837,221	+7.1%	Shares	Sole	2023-11-13
2023-06-30	$90,217,094	781,845	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.